care-at-home

(4)
Legend
Christopher McGhee Sold Current Health for $400 Million. Then He Bought It Back.
Founder · Executive · Operator

Christopher McGhee Sold Current Health for $400 Million. Then He Bought It Back.

A medical student turned a family frustration into a care-at-home company, sold it to Best Buy, walked away, and returned for an unusual second act: making the hard parts of healthcare happen beyond hospital walls.

christopher-mcghee · current-healthRead →
Company
Best Buy Paid $400 Million for Current Health. Then Its Founder Bought the Company Back - and Narrowed the Bet
Health · Ai · Saas

Best Buy Paid $400 Million for Current Health. Then Its Founder Bought the Company Back - and Narrowed the Bet

Current Health began with a wearable, grew into a hospital-at-home operating system, and became a $400 million retail-health wager. Its second act is more disciplined: help hospitals and drugmakers move the hardest care out of the building without making clinicians gamble on safety.

current-health · hospital-at-homeRead →
Company
The Healthcare Holding Company Building a Front Door That Opens at Home
Health · Enterprise

The Healthcare Holding Company Building a Front Door That Opens at Home

True Ventures Group is assembling home care, remote monitoring and virtual medicine under one roof - a practical bet that the hardest part of healthcare is often what happens between appointments.

healthcare-holding-company · home-careRead →
Legend
Chris Altchek
Founder · Executive · Operator

Chris Altchek

Chris Altchek is the founder and CEO of Cadence, a New York health-tech company that runs remote patient monitoring and virtual care for chronic conditions on behalf of large U.S. health systems. He built the company after selling his first venture, the millennial media brand Mic, which he co-founded at 23 with high-school friend Jake Horowitz. A Harvard social studies graduate and former Goldman Sachs analyst who also worked in the Bloomberg administration and the White House, Altchek pivoted from media to medicine through an entrepreneur-in-residence stint at Thrive Capital. Cadence reached a reported $1 billion valuation in 2021 after a $100 million Series B led by Coatue, and now monitors tens of thousands of patients across more than 20 states.

chris-altchek · cadenceRead →